---
figid: PMC9257957__etm-24-02-11441-g00
pmcid: PMC9257957
image_filename: etm-24-02-11441-g00.jpg
figure_link: /pmc/articles/PMC9257957/figure/f1-ETM-24-2-11441/
number: Figure 1
figure_title: ''
caption: 'Cell viability of K562 cells treated with different concentrations of (A)
  IM (1-10-100 µM) and (B) Das (1-5-10-100-100-1,000-2,500 nM) for 24 and 48 h. *P<0.05
  K562 cells incubated with 100 µM IM vs. K562 control cells; #P<0.05 K562 cells incubated
  with 2,500 nM Das vs. K562 control cells (n=5). IM, imatinib; Das, dasatinib.'
article_title: Verbascoside potentiates the effect of tyrosine kinase inhibitors on
  the induction of apoptosis and oxidative stress via the Abl-mediated MAPK signalling
  pathway in chronic myeloid leukaemia.
citation: Gulsum Akgun-Cagliyan, et al. Exp Ther Med. 2022 Aug;24(2):514.
year: '2022'

doi: 10.3892/etm.2022.11441
journal_title: Experimental and Therapeutic Medicine
journal_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos

keywords:
- chronic myeloid leukaemia
- imatinib
- dasatinib
- verbascoside
- MAPK
- Abl (Phospho-Tyr412)

---
